注冊以創建關於儀器的通知
你所追隨的作者的經濟活動和內容
免費註冊 已有帳戶? 登入
PDS Biotechnology Corp是一家臨床階段的免疫治療公司。該公司致力於開發一系列分子靶向免疫療法。該公司擁有T細胞激活平台,旨在訓練免疫系統攻擊和摧毀疾病。該公司的Versamune用於治療腫瘤學,Infectimune用於治療傳染病。Infectimune還旨在促進誘導疾病特異性中和抗體。該公司的免疫腫瘤學產品候選者俱有潛在能力,可用作組合候選產品的組成部分,以提供針對一系列晚期和/或難治性癌症的治療。該公司開發有針對性的候選產品來治療多種癌症,包括人乳頭瘤病毒(HPV)相關癌症、黑色素瘤、結腸直腸癌、肺癌、乳腺癌和前列腺癌。該公司的傳染病候選產品作為預防COVID-19和普遍流感的疫苗具有潛在的價值。
名稱 | 年齡 | 成立於 | 主旨 |
---|---|---|---|
Neil Gross | - | - | Member of Scientific Advisory Board |
Frank K. Bedu-Addo | 59 | 2019 | President, CEO & Director |
Jerold G. Woodward | - | - | Member of Scientific Advisory Board |
Ilian Petkov Iliev | 49 | 2020 | Director |
Otis W. Brawley | 64 | 2020 | Independent Director |
Mark W. Frohlich | 62 | 2021 | Member of Scientific Advisory Board |
Richard Sykes | 79 | 2019 | Independent Director |
Olivera J. Finn | - | 2021 | Member of Scientific Advisory Board |
Gregory G. Freitag | 62 | 2019 | Independent Director |
Leaf Huang | - | - | Member of Scientific Advisory Board |
Lisa Rohan | - | - | Chair of the Scientific Advisory Board |
Samir N. Khleif | 60 | - | Member of Scientific Advisory Board |
Mark H. Einstein | - | - | Member of Scientific Advisory Board |
Darron R. Brown | - | - | Member of Scientific Advisory Board |
Kamil Ali-Jackson | 65 | 2020 | Independent Director |
你確定要封鎖 %USER_NAME%?
此舉將會令你與 %USER_NAME% 之間無法看見對方的Investing.com貼文。
%USER_NAME% 已成功加入你的封鎖清單
你剛解除此人的封鎖,必須等候 48 小時後才可再次封鎖。
我覺得這個評論是:
謝謝!
您的報告已被發送到我們的版主審核